Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer

Oncolytic strains of vaccinia virus are currently in clinical development with clear evidence of safety and promising signs of efficacy. Addition of therapeutic genes to the viral genome may increase the therapeutic efficacy of vaccinia. We evaluated the therapeutic potential of vaccinia virus expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansfield, D C, Kyula, J N, Rosenfelder, N, Chao-Chu, J, Kramer-Marek, G, Khan, A A, Roulstone, V, McLaughlin, M, Melcher, A A, Vile, R G, Pandha, H S, Khoo, V, Harrington, K J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827015/
https://www.ncbi.nlm.nih.gov/pubmed/26814609
http://dx.doi.org/10.1038/gt.2016.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827015/
https://www.ncbi.nlm.nih.gov/pubmed/26814609
http://dx.doi.org/10.1038/gt.2016.5

Ejemplares similares